← SynDRA
ORTERONEL
SynDRA canonical compound SYN0028398 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
CYP17A1
Mechanism of action
androgen biosynthesis inhibitor | androgen receptor antagonist | cytochrome P450 inhibitor
All known targets
CYP17A1
Mechanisms of action (all sources)
CYP17A1 INHIBITOR
Cytochrome P450 17A1 inhibitor
androgen biosynthesis inhibitor
AR ANTAGONIST
cytochrome P450 inhibitor
CYP17A1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
CYP21A2
CYP1A2
CYP2A6
CYP2B6
CYP2C19
CYP2C8
CYP2C9
CYP2D6
CYP2E1
CYP3A4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
CP2D6
Cross-references
PubChem CID:
9883029
ChEMBL:
CHEMBL1921976
DrugBank:
DB12066
ChEBI:
94965
KEGG:
D10146
PDB:
7D6
Wikipedia:
Orteronel
TTD: D0X3OI
Synonyms
TAK-700
TAK 700
orteronelum
UE5K2FNS92
RefChem:856930
DTXCID101748551
CYP17A1 Lyase Inhibitor TAK-700
Androgen Synthesis Inhibitor TAK-700
(S)-Orteronel
TAK700
TAK-700 (S-form)
Orteronel [INN]
Orteronel [USAN:INN]
UNII-UE5K2FNS92
(+)-orteronel
MFCD20528078
ORTERONEL [JAN]
Orteronel (JAN/USAN)
ORTERONEL [USAN]
ORTERONEL [WHO-DD]
orb1689515
SCHEMBL6126076
SCHEMBL29363567
GTPL13853
S-TAK-700
EX-A159
CHEBI:231353
(S)-TAK700
csa:566939-85-3;Orteronel
GLXC-06640
HMS3750I13
RXA93985
Orteronel,CAS:566939-85-3
BDBM50358201
CYP17A1 Inhibitor II, TAK-700
AKOS030526849
CS-0580
SB16686
NCGC00378767-02
Look up ORTERONEL in the interactive SynDRA portal →